From the Editor
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Device... Read More
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. Read Less
Johnson & Johnson Company Stats
As of August 2024
- Industry
- Drugs & Biotechnology
- Founded
- 1886
- Headquarters
- New Brunswick, New Jersey
- Country/Territory
- United States
- Chief Executive Officer
- Joaquin Duato
- Employees
- 48,115
Forbes Lists
America's Best Employers By State (2024)
#22
Best Employers for Women (2024)
#153
Canada's Best Employers For Diversity (2024)
#45
Global 2000 (2024)
#103 - SALES
#35 - PROFITS
#241 - ASSETS
#24 - MARKET VALUE
#2
Net Zero Leaders (2024)
#342
Best Employers for New Grads (2024)
#24
Best Employers for Diversity (2024)
#173
America's Best Large Employers (2024)
#89
World's Top Companies for Women (2023)
#56
World's Best Employers (2023)
#151
Canada's Best Employers (2023)Dropped off in 2024
#61
Mexico's Best Employers (2022)
#45
Just Companies (2021)
#63
Top Regarded Companies (2019)
#45
America's Largest Public Companies (2018)
Johnson & Johnson Financial Summary
Select list year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Revenue
$89.7B
Assets
$172B
Profits
$17.5B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$96.3B
Assets
$196B
Profits
$12.7B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$94.9B
Assets
$182B
Profits
$19.8B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$82.6B
Assets
$174.9B
Profits
$14.7B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$82.8B
Assets
$155B
Profits
$17.2B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$81.6B
Assets
$153B
Profits
$14.7B
Revenue
$78.7B
Assets
$156.6B
Profits
$1.2B
Revenue
$71.9B
Assets
$141.2B
Profits
$16.4B
Revenue
$70.2B
Assets
$133.4B
Profits
$15.4B
Revenue
$74.2B
Assets
$131.1B
Profits
$16.3B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$71.3B
Assets
$132.7B
Profits
$13.8B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$67.2B
Assets
$121.3B
Profits
$10.9B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$2.5B
Revenue
$61.6B
Assets
$102.9B
Profits
$13.3B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Johnson & Johnson (JNJ) Stock Price Performance
Johnson & Johnson (JNJ) Stock Key Data
SummaryAdditional DataAnalystsHistorical Quotes
Key Data
Previous Close
164.23
Open
164.12
Days Range
163.81 x 165.98
Volume
7,971,017
52 Week Range
143.13 x 165.98
Market Cap
$399.27B
P/E Ratio (ttm)
24.93
Forward P/E
16.74
Diluted EPS (ttm)
6.65
Dividends Per Share
4.81
Dividend Yield
2.99%
Ex-Dividend Date
Aug 27, 2024
Valuation Measures
P/E Ratio (ttm)
24.93
Forward P/E
16.74
Price to Sales (ttm)
4.67
Price to Book Value (ttm)
5.58
Price to Tangible Book Value (ttm)
N/A
Total Enterprise Value to EBIT (ttm)
17.20
Total Enterprise Value to EBITDA (ttm)
13.29
Total Enterprise Value to Total Revenue (ttm)
4.80
Profitability Metrics
Gross Margin (ttm)
69.43%
Operating Margin (ttm)
27.90%
Net Margin (ttm)
43.91%
Return on Assets (ttm)
8.10%
Return on Equity (ttm)
22.15%
Revenue and Earnings Metrics
Revenue (ttm)
$86.58B
Revenue Per Share (ttm)
35.54
Revenue Growth (y/o/y)
5.13%
EBITDA (ttm)
$31.04B
EBITDA Growth (y/o/y)
3.81%
Diluted EPS (ttm)
6.65
Diluted EPS Growth (y/o/y)
41.75
Cash and Debt Metrics
Total Cash
$25.48B
Total Cash Per Share
10.34
Total Debt
$41.49B
Total Debt/Equity
58.00%
Current Ratio
1.07
All values as of most recently reported quarter unless otherwise noted.
Consensus Recommendation
Outperform
Consensus Price
170.67
Range of Price Targets
150.00 to 215.00
Range of EPS
9.25 to 10.58
Consensus EPS
9.91
Consensus Revenue
$89.54B
Range of Revenue
$88.67B to $90.39B
- Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.
- EPS and Revenue estimates are for the next 12 months.
| DATE | OPEN | HIGH | LOW | CLOSE | ADJUSTED CLOSE | VOLUME |
| Aug 30, 2024 | 164.12 | 165.98 | 163.81 | 165.86 | 165.86 | 7,971,017 |
| Aug 29, 2024 | 164.63 | 164.72 | 163.36 | 164.23 | 164.23 | 7,390,125 |
| Aug 28, 2024 | 163.00 | 165.00 | 162.71 | 163.92 | 163.92 | 5,187,198 |
| Aug 27, 2024 | 163.50 | 164.03 | 162.16 | 162.95 | 162.95 | 4,388,728 |
| Aug 26, 2024 | 164.17 | 165.71 | 163.54 | 164.61 | 163.37 | 6,870,622 |
| Aug 23, 2024 | 162.50 | 164.22 | 161.69 | 164.13 | 162.89 | 7,093,429 |
| Aug 22, 2024 | 162.00 | 162.49 | 160.79 | 162.35 | 161.13 | 6,552,142 |
| Aug 21, 2024 | 160.40 | 161.48 | 160.31 | 161.43 | 160.21 | 5,019,375 |
| Aug 20, 2024 | 160.00 | 160.93 | 159.67 | 160.16 | 158.95 | 7,275,133 |
| Aug 19, 2024 | 159.46 | 160.29 | 159.13 | 159.63 | 158.43 | 4,408,517 |
Related People & Companies
Johnson family
Company Stakeholder
Bartell Drugs
Related by Industry: Drugs & Biotechnology
New York Knicks
Located in New York-Northern New Jersey-Long Island, NY-NJ-PA Metropolitan Area
More on Forbes
15 minutes ago
DirecTV Without ABC And ESPN: Licensing Dispute With Disney ExplainedDirecTV “chose to deny” millions of viewers access to the U.S. Open and the NFL, Disney claims.
ByTy RoushForbes Staff
21 minutes ago
College Baseball Accelerates Development Of Top Major League ProspectsCollege baseball programs are accelerating the development of top major league prospects due to advancements in coaching, research, technology and quality of competition.
ByWayne G. McDonnell, Jr.Contributor
40 minutes ago
Netflix Announces Film ‘Mantis,’ A Spin-Off From ‘Kill Boksoon’Netflix has confirmed the production of "Mantis," an action film that follows Mantis, an ace assassin who returns to a collapsed-order hired killer industry.
ByMarc BermanSenior Contributor
40 minutes ago
5 Of The Best Restaurants In London: September 2024Nigerian tapas, arguably the best Mexican restaurant in the world, and more.
ByLela LondonSenior Contributor
1 hour ago
NL’s Wild Wild-Card Chase Tightens As Baseball Season Starts Last MonthAt the Labor Day marker, five teams are bidding for three NL wild-card berths.
ByDan SchlossbergContributor
1 hour ago
The Best New TV Shows Streaming In September 2024 On Netflix, Hulu And MoreCheck out the best new and returning TV shows streaming in September, including "The Pengiun," "Agatha All Along," "The Perfect Match," and more.
ByMonica MercuriContributor
2 hours ago
Summer’s Box Office Blockbusters—And Flops: Starring ‘Inside Out 2’ And ‘Furiosa’Billion-dollar blockbusters “Inside Out 2” and “Deadpool & Wolverine” led a strong summer box office season that helped turn around a shaky start to the year.
ByConor MurrayForbes Staff
2 hours ago
Telegram Now Under Fire Over Deepfake p*rn In South KoreaSouth Korean police said it is investigating whether Telegram’s hands-off approach to moderation could be allowing digital crime to flourish as French prosecutors charge billionaire founder Pavel Durov with enabling criminality on the app.
ByRobert HartForbes Staff
3 hours ago
Two First Team Real Madrid Players Confirmed Injured In Same DayTwo Real Madrid first team stars, who both started in Sunday's 2-0 win over Real Betis, have been confirmed injured on Monday.
ByTom SandersonSenior Contributor
3 hours ago
A Tale Of Two Villages: Solving Homelessness Requires New Building CodesPeople living outside face the elements and other hazards, but offering improvised shelter on private property is usually illegal based on zoning and building codes.
ByRoger ValdezContributor
3 hours ago
History Of U.S. Open Through Newport And New YorkThe current iteration of the U.S. Open has a strong history in Flushing Meadows, that much is certain.
ByTim NewcombContributor
3 hours ago
Summer TV Dominated By Trump, Harris, Biden—And Simone BilesBig election moments were the most-watched events of the summer as politics continue to dominate television viewership.
ByMary Whitfill RoeloffsForbes Staff
4 hours ago
Summer Books 2024: ‘The Women’ And New ‘The Housemaid’ Ruled All Beach ReadingGet Forbes Breaking News Text Alerts: We’re launching text message alerts so you'll always know the biggest stories shaping the day’s headlines.
ByMary Whitfill RoeloffsForbes Staff
4 hours ago
‘Paying For It’ Ponders Love And Sex Via Graphic Novel AdaptationSook-Yin Lee, who inspired a character in the graphic novel 'Paying For It,' adapts the controversial story into a film.
ByJoan MacDonaldContributor
Aug 20, 2024
Meet America’s Best Employers By State 2024We surveyed more than 160,000 workers across the country to find out which organizations employees recommend the most. Winners range from small firms to large institutions.
ByRachel Rabkin PeachmanForbes Staff
Aug 16, 2024
America’s Best Employers By State 2024 MethodologyForbes' upcoming list features the most-recommended employers in all industries across the United States.
ByRachel Rabkin PeachmanForbes Staff
